NDAC meeting
This article was originally published in The Tan Sheet
Executive Summary
The Nonprescription Drugs advisory panel will not discuss products such as Elidel or Protopic during its March 24 joint session with the Dermatologic & Ophthalmic Drugs Advisory committee as previously reported; the two committees will evaluate what constitutes and adequate safety profile when switching topical corticosteroids Rx-to OTC. Elidel and Protopic are not topical corticosteroids as previously reported in "The Tan Sheet"...